07:00 , Aug 11, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Autoimmune disease

Indication Target/marker/ pathway Summary Licensing status Publication and contact information Autoimmune disease Rheumatoid arthritis (RA) Carboxypeptidase B2 (CPB2; TAFI); complement 5a (C5a) Mouse and human studies suggest the enzyme CPB2 could help treat RA. In...